Lataa...
Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells
Pancreatic cancer (PanC) is one of the deadliest malignancies worldwide and frontline treatment with gemcitabine becomes eventually ineffective due to increasing PanC resistance, suggesting additional approaches are needed to manage PanC. Recently, we have shown the efficacy of bitter melon juice (B...
Tallennettuna:
| Julkaisussa: | Mol Carcinog |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6118209/ https://ncbi.nlm.nih.gov/pubmed/29727019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22833 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|